The Extraordinary Rise and Fall of a Promising Cancer Treatment

 A Story of Lies, Greed and Dishonesty

In the middle of the twentieth century, Andrew Ivy, MD, PhD, was one of the most respected scientists in America. Vice President of the University of Illinois and a director of the American Cancer Society, he was a pillar of the medical establishment.

His career would no doubt have continued to blossom if he had not made a crucial error of judgment. He decided to investigate a promising new non-toxic cancer drug. That's when his world fell apart.

Here is how it came about.

Continued...